
Biobin 500mg Injection
Marketer
Biochem Pharmaceutical Industries
Salt Composition
Cytarabine (500mg)
Overview Biobin 500mg Injection
Hemoblast 500mg Injection is indicated for the management of specific hematologic malignancies. Its application may extend to other conditions as directed by a physician, potentially as part of a multi-drug chemotherapeutic regimen. Administration is intravenous or subcutaneous, performed by a qualified healthcare provider. Dosage and frequency are individualized by your doctor based on your condition and may be adjusted. Strict adherence to the prescribed regimen is crucial; improper use can lead to severe adverse reactions. Therapeutic effects may not be immediately apparent, requiring weeks or months; discontinue only under medical guidance. Common side effects include dermatological reactions (rash, skin lesions), gastrointestinal upset (nausea, vomiting), and alopecia. Hematologic suppression (reduced blood cell counts) is possible, increasing infection and bleeding risks. Report signs of infection (chills), abnormal bleeding/bruising, or melena (dark, tarry stools) immediately. Regular monitoring of blood counts, hepatic and renal function, and uric acid levels is necessary. Prior to treatment, disclose any pre-existing bleeding disorders, hepatic or renal impairment, or concurrent use of anti-infective medications. Drug interactions are possible; provide your physician a complete medication list. Use during pregnancy or lactation is contraindicated; effective contraception is mandatory for both partners throughout the treatment period.
Uses of Biobin 500mg Injection
Hematologic malignancy
Major Benefits of Biobin 500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Biobin 500mg Injection:
- Rash
- Skin ulcer
- Nausea
- Vomiting
- Hair loss
- Abdominal pain
- Anal ulcers
- Anemia (low number of red blood cells)
- Decreased white blood cell count
- Fever
- Infection
- Abnormal liver function
- Low blood platelets
- Mouth ulcer
- Pneumonia
- Sepsis
- Mouth sore
- Stomatitis (Inflammation of the mouth)
How to use Biobin 500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Biobin 500mg Injection works:
Biobin 500mg Injection halts cancer cell proliferation by disrupting DNA and RNA synthesis through the replacement of essential molecular components, thus inhibiting cancerous growth and replication.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Biobin 500mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Biobin 500mg Injection during pregnancy poses a confirmed risk to fetal development, hence its inadvisability. Nevertheless, in exceptionally dire circumstances where the potential advantages outweigh the hazards, a physician might exceptionally authorize its use. Physician consultation is essential.
Breast feedingUNSAFE
Administration of Biobin 500mg Injection is contraindicated while breastfeeding due to potential infant toxicity. Evidence indicates a risk of harmful effects to the nursing infant.
DrivingUNSAFE
Administering Biobin 500mg Injection may result in adverse reactions that could impair driving capabilities.
KidneySAFE IF PRESCRIBED
Biobin 500mg Injection may be administered to patients with kidney disease without altering the dosage. Nevertheless, consultation with a physician is advised for individuals with pre-existing kidney conditions.
LiverCONSULT YOUR DOCTOR
Data regarding Biobin 500mg Injection's use in individuals with hepatic impairment is scarce. Physician consultation is advised. This limited data necessitates a prudent approach to administering Biobin 500mg Injection to patients with liver conditions.
What if you forget to take Biobin 500mg Injection :
NA
Facts to Know About Biobin 500mg Injection
| Label | Value |
|---|---|
| Chemical Category | Pyrimidine Nucleoside Analogue |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Metabolic Inhibitors |
